Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy
Lim, Su Y, Lee, Jenny H, Gide, Tuba N, Menzies, Alexander M, Guminski, Alexander, Carlino, Matteo S, Breen, Edmond J, Yang, Jean Y H, Ghazanfar, Shila, Kefford, Richard F, Scolyer, Richard A, Long, Georgina V, Rizos, Helen
Published in Clinical cancer research (01.03.2019)
Published in Clinical cancer research (01.03.2019)
Get full text
Journal Article
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Lee, Jenny H., Shklovskaya, Elena, Lim, Su Yin, Carlino, Matteo S., Menzies, Alexander M., Stewart, Ashleigh, Pedersen, Bernadette, Irvine, Malama, Alavi, Sara, Yang, Jean Y. H., Strbenac, Dario, Saw, Robyn P. M., Thompson, John F., Wilmott, James S., Scolyer, Richard A., Long, Georgina V., Kefford, Richard F., Rizos, Helen
Published in Nature communications (20.04.2020)
Published in Nature communications (20.04.2020)
Get full text
Journal Article
BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact
RIZOS, Helen, MENZIES, Alexander M, HOWIE, Julie, SAW, Robyn, THOMPSON, John F, KEFFORD, Richard F, SCOLYER, Richard A, LONG, Georgina V, PUPO, Gulietta M, CARLINO, Matteo S, FUNG, Carina, HYMAN, Jessica, HAYDU, Lauren E, MIJATOV, Branka, BECKER, Therese M, BOYD, Suzanah C
Published in Clinical cancer research (01.04.2014)
Published in Clinical cancer research (01.04.2014)
Get full text
Journal Article
Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
Vilain, Ricardo E, Menzies, Alexander M, Wilmott, James S, Kakavand, Hojabr, Madore, Jason, Guminski, Alexander, Liniker, Elizabeth, Kong, Benjamin Y, Cooper, Adam J, Howle, Julie R, Saw, Robyn P M, Jakrot, Valerie, Lo, Serigne, Thompson, John F, Carlino, Matteo S, Kefford, Richard F, Long, Georgina V, Scolyer, Richard A
Published in Clinical cancer research (01.09.2017)
Published in Clinical cancer research (01.09.2017)
Get full text
Journal Article
Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma
ASCIERTO, Paolo A, MINOR, David, HAMID, Omid, AMARAVADI, Ravi, SIMEONE, Ester, WILHELM, Tabea, KIM, Kevin B, LONG, Georgina V, MARTIN, Anne-Marie, MAZUMDAR, Jolly, GOODMAN, Vicki L, TREFZER, Uwe, RIBAS, Antoni, LEBBE, Celeste, O'HAGAN, Anne, ARYA, Niki, GUCKERT, Mary, SCHADENDORF, Dirk, KEFFORD, Richard F, GROB, Jean-Jacques
Published in Journal of clinical oncology (10.09.2013)
Published in Journal of clinical oncology (10.09.2013)
Get full text
Journal Article
Conference Proceeding
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
LONG, Georgina V, MENZIES, Alexander M, NAGRIAL, Adnan M, HAYDU, Lauren E, HAMILTON, Anne L, MANN, Graham J, HUGHES, T. Michael, THOMPSON, John F, SCOLYER, Richard A, KEFFORD, Richard F
Published in Journal of clinical oncology (01.04.2011)
Published in Journal of clinical oncology (01.04.2011)
Get full text
Journal Article
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Long, Georgina V, Dr, Trefzer, Uwe, MD, Davies, Michael A, MD, Kefford, Richard F, Prof, Ascierto, Paolo A, MD, Chapman, Paul B, MD, Puzanov, Igor, MD, Hauschild, Axel, MD, Robert, Caroline, PhD, Algazi, Alain, MD, Mortier, Laurent, Prof, Tawbi, Hussein, PhD, Wilhelm, Tabea, MD, Zimmer, Lisa, MD, Switzky, Julie, MSN, Swann, Suzanne, PhD, Martin, Anne-Marie, PhD, Guckert, Mary, MSN, Goodman, Vicki, MD, Streit, Michael, MD, Kirkwood, John M, Prof, Schadendorf, Dirk, Prof
Published in The lancet oncology (01.11.2012)
Published in The lancet oncology (01.11.2012)
Get full text
Journal Article
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Long, Georgina V., Fung, Carina, Menzies, Alexander M., Pupo, Gulietta M., Carlino, Matteo S., Hyman, Jessica, Shahheydari, Hamideh, Tembe, Varsha, Thompson, John F., Saw, Robyn P., Howle, Julie, Hayward, Nicholas K., Johansson, Peter, Scolyer, Richard A., Kefford, Richard F., Rizos, Helen
Published in Nature communications (02.12.2014)
Published in Nature communications (02.12.2014)
Get full text
Journal Article
PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
Madore, Jason, Vilain, Ricardo E., Menzies, Alexander M., Kakavand, Hojabr, Wilmott, James S., Hyman, Jessica, Yearley, Jennifer H., Kefford, Richard F., Thompson, John F., Long, Georgina V., Hersey, Peter, Scolyer, Richard A.
Published in Pigment cell and melanoma research (01.05.2015)
Published in Pigment cell and melanoma research (01.05.2015)
Get full text
Journal Article
Liquid biomarkers in melanoma: detection and discovery
Lim, Su Yin, Lee, Jenny H, Diefenbach, Russell J, Kefford, Richard F, Rizos, Helen
Published in Molecular cancer (17.01.2018)
Published in Molecular cancer (17.01.2018)
Get full text
Journal Article
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
Shi, Hubing, Hugo, Willy, Kong, Xiangju, Hong, Aayoung, Koya, Richard C, Moriceau, Gatien, Chodon, Thinle, Guo, Rongqing, Johnson, Douglas B, Dahlman, Kimberly B, Kelley, Mark C, Kefford, Richard F, Chmielowski, Bartosz, Glaspy, John A, Sosman, Jeffrey A, van Baren, Nicolas, Long, Georgina V, Ribas, Antoni, Lo, Roger S
Published in Cancer discovery (01.01.2014)
Published in Cancer discovery (01.01.2014)
Get full text
Journal Article
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma
Delord, Jean-Pierre, Robert, Caroline, Nyakas, Marta, McArthur, Grant A, Kudchakar, Ragini, Mahipal, Amit, Yamada, Yasuhide, Sullivan, Ryan, Arance, Ana, Kefford, Richard F, Carlino, Matteo S, Hidalgo, Manuel, Gomez-Roca, Carlos, Michel, Daniela, Seroutou, Abdelkader, Aslanis, Vassilios, Caponigro, Giordano, Stuart, Darrin D, Moutouh-de Parseval, Laure, Demuth, Tim, Dummer, Reinhard
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma
Long, Georgina V, Wilmott, James S, Capper, David, Preusser, Matthias, Zhang, Yuxiao E, Thompson, John F, Kefford, Richard F, von Deimling, Andreas, Scolyer, Richard A
Published in The American journal of surgical pathology (01.01.2013)
Published in The American journal of surgical pathology (01.01.2013)
Get more information
Journal Article
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
Falchook, Gerald S, Dr, Long, Georgina V, PhD, Kurzrock, Razelle, Prof, Kim, Kevin B, MD, Arkenau, Tobias H, PhD, Brown, Michael P, PhD, Hamid, Omid, MD, Infante, Jeffrey R, MD, Millward, Michael, MD, Pavlick, Anna C, MD, O’Day, Steven J, MD, Blackman, Samuel C, PhD, Curtis, C Martin, BA, Lebowitz, Peter, PhD, Ma, Bo, PhD, Ouellet, Daniele, PhD, Kefford, Richard F, Prof
Published in The Lancet (British edition) (19.05.2012)
Published in The Lancet (British edition) (19.05.2012)
Get full text
Journal Article
PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients
Kakavand, Hojabr, Wilmott, James S, Menzies, Alexander M, Vilain, Ricardo, Haydu, Lauren E, Yearley, Jennifer H, Thompson, John F, Kefford, Richard F, Hersey, Peter, Long, Georgina V, Scolyer, Richard A
Published in Clinical cancer research (15.07.2015)
Published in Clinical cancer research (15.07.2015)
Get full text
Journal Article
Interferon Signaling Is Frequently Downregulated in Melanoma
Alavi, Sara, Stewart, Ashleigh Jacqueline, Kefford, Richard F, Lim, Su Yin, Shklovskaya, Elena, Rizos, Helen
Published in Frontiers in immunology (21.06.2018)
Published in Frontiers in immunology (21.06.2018)
Get full text
Journal Article
Intrapatient homogeneity of BRAFV600E expression in melanoma
Menzies, Alexander M, Lum, Trina, Wilmott, James S, Hyman, Jessica, Kefford, Richard F, Thompson, John F, O'Toole, Sandra, Long, Georgina V, Scolyer, Richard A
Published in The American journal of surgical pathology (01.03.2014)
Published in The American journal of surgical pathology (01.03.2014)
Get more information
Journal Article
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
Carlino, Matteo S., Todd, Jason R., Gowrishankar, Kavitha, Mijatov, Branka, Pupo, Gulietta M., Fung, Carina, Snoyman, Stephanie, Hersey, Peter, Long, Georgina V., Kefford, Richard F., Rizos, Helen
Published in Molecular oncology (01.05.2014)
Published in Molecular oncology (01.05.2014)
Get full text
Journal Article
Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma
Menzies, Alexander M, Haydu, Lauren E, Carlino, Matteo S, Azer, Mary W F, Carr, Peter J A, Kefford, Richard F, Long, Georgina V
Published in PloS one (06.01.2014)
Published in PloS one (06.01.2014)
Get full text
Journal Article
Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)
FALCHOOK, Gerald S, LONG, Georgina V, CHIN, Melvin T, O'DAY, Steven J, BLACKMAN, Samuel C, CURTIS, C. Martin, LEBOWITZ, Peter, BO MA, OUELLET, Daniele, KEFFORD, Richard F, KURZROCK, Razelle, KIM, Kevin B, ARKENAU, H.-Tobias, BROWN, Michael P, HAMID, Omid, INFANTE, Jeffrey R, MILLWARD, Michael, PAVLICK, Anna
Published in Clinical cancer research (01.09.2014)
Published in Clinical cancer research (01.09.2014)
Get full text
Journal Article